AP NEWS

Singapore Contract Research Outsourcing Market Outlook to 2022 - by Phase, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR - ResearchAndMarkets.com

November 7, 2018

DUBLIN--(BUSINESS WIRE)--Nov 7, 2018--The “Singapore Contract Research Outsourcing Market Outlook to 2022 - by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR” report has been added to ResearchAndMarkets.com’s offering.

The report includes market projections for the future and analyst recommendations highlighting the major opportunities and cautions.

Singapore CRO market has inclined at positive CAGR during 2013-2017. The market is majorly driven by patent expiration of main revenue-generating drugs, competition from the generic versions of branded drugs, and increasing research and development costs which have pushed pharmaceuticals manufacturers to look for strategies to cut costs and speed up the R&D processes.

The manufacturers struggle to renew their pipelines while facing the challenges of efficient drug discovery which has propelled growth in the contract research outsourcing industry in Singapore. Further, the market is supported by best in class infrastructure for research, highly skilled workforce, Strong intellectual property (IP) and legal infrastructure and government support.

CRO market in Singapore is dominated by MNCs that are capitalizing on the increasing government support for clinical research and foreign investment. The number of clinical trials increased due to establishment of more clinical trial units and more patient participation that gives them the opportunity to access innovative experimental treatments that are not yet available in the market.

Key Topics Covered:

1. Research Methodology

2. Singapore Contract Research Organization Market - Executive Summary

3. Singapore Healthcare Ecosystem

4. Singapore Healthcare System

5. Singapore Healthcare Key Metrics

6. Comparative Analysis with Other Asian Countries

7. Singapore Contract Research Organization Market: Overview and Market Size- 2013-2017

8. Singapore Contract Research Organization Market Segmentation

9. Singapore Contract Research Organization Market - Growth Drivers

10. Singapore Contract Research Organization Market - Government Regulations

11. Value Chain in Contract Research Organization

12. CRO Market Competitive Landscape

13. Singapore CRO Market Future Outlook and Projections, 2018-2022

Companies Mentioned

Covance (Asia) Pte Ltd EPS Global Research Pte Ltd. ICON Clinical Research Pte Ltd Maccine Pte Ltd Novotech PAREXEL International Corporation Phoenix Pharma Central Services (S) Pte Ltd PPD Development (S) Pte Ltd PRA Singapore Quintiles East Asia Pte Ltd SGS Singapore Clinical Research Institute (SCRI) Syneos Health

For more information about this report visit https://www.researchandmarkets.com/research/bd2nkl/singapore?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005360/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery,Data Storage and Management ,Bioinformatics,Laboratory Testing

KEYWORD:

INDUSTRY KEYWORD: PROFESSIONAL SERVICES CONSULTING

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/07/2018 04:20 AM/DISC: 11/07/2018 04:20 AM

http://www.businesswire.com/news/home/20181107005360/en

AP RADIO
Update hourly